financetom
Business
financetom
/
Business
/
Apex Treasury Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about November 17, 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apex Treasury Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about November 17, 2025
Nov 12, 2025 1:16 PM

New York, New York, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Apex Treasury Corporation ( APXTU ) (the “Company”) announced that holders of the units sold in the Company’s upsized initial public offering of 34,470,000 units, which includes 4,470,000 units issued pursuant to the partial exercise by the underwriters of their overallotment option, completed on October 29, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about November 17, 2025. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “APXTU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “APXT” and “APXTW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Efficiency d/b/a Lucky Lucko, Inc., the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

A registration statement relating to these securities has become effective pursuant to Section 8(a) of the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Cautionary Note Concerning Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s search for an initial business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

About Apex Treasury Corporation ( APXTU )

Apex Treasury Corporation ( APXTU ) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. While the Company may pursue an initial business combination in any sector or geographic region, it intends initially to focus on opportunities in the digital asset sector.

Contact

Ajmal Rahman

Chairman and Co-Chief Executive Officer

Apex Treasury Corporation ( APXTU )

[email protected]

Image: https://www.globenewswire.com/newsroom/ti?nf=OTU3NDMwOCM3MjU5OTQ5IzUwMDE1MzkzNQ==

Image: https://ml.globenewswire.com/media/ZmIzYjdmYWQtNTJiZS00Y2UzLThiZWQtYmU4YzdlYWRmOTEwLTUwMDE1MzkzNS0yMDI1LTExLTEyLWVu/tiny/Apex-Treasury-Corp.png

Source: Apex Treasury Corp ( APXTU )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Assembly Biosciences Doses First Subject in Phase 1a Trial of Hepatitis Delta Virus Therapy Candidate; Shares Up
Assembly Biosciences Doses First Subject in Phase 1a Trial of Hepatitis Delta Virus Therapy Candidate; Shares Up
Feb 26, 2025
10:22 AM EST, 02/26/2025 (MT Newswires) -- Assembly Biosciences ( ASMB ) shares were higher Wednesday morning after the company said that a first subject has been dosed in the phase 1a trial of ABI-6250, its hepatitis delta virus entry inhibitor candidate. The study aims to evaluate the safety, tolerability and pharmacokinetics of the therapy across single and multiple ascending...
Market Chatter: Merck Looks to Increase Staff in India, Executive Says
Market Chatter: Merck Looks to Increase Staff in India, Executive Says
Feb 26, 2025
10:26 AM EST, 02/26/2025 (MT Newswires) -- Merck ( MRK ) expects to have about 2,700 employees in India by yearend, Reuters reported Wednesday, citing Executive Vice President Dave Williams. In a couple of years, I fully expect we'll double that number or more, Williams said at the BioAsia conference held in India, according to Reuters. The company's sites in...
DMY Squared Technology, Horizon Quantum Sign Business Combination Deal
DMY Squared Technology, Horizon Quantum Sign Business Combination Deal
Feb 26, 2025
10:26 AM EST, 02/26/2025 (MT Newswires) -- DMY Squared Technology Group ( DMYY ) and Horizon Quantum Computing said Wednesday they have signed a non-binding letter of intent for a business combination. Under the terms, the pre-money equity value of Horizon Quantum is roughly $500 million, the companies said, adding that they intend to execute an agreement in Q2 and...
EU approves $2.3 billion takeover of Infinera by Nokia
EU approves $2.3 billion takeover of Infinera by Nokia
Feb 26, 2025
BRUSSELS (Reuters) - The EU Commission on Wednesday said it had unconditionally approved the $2.3 billion acquisition of U.S. optical semiconductors and networking equipment maker Infinera ( INFN ) by Nokia. The commission said the takeover raised no concerns, as the companies' combined market share in the supply of optical transport equipment would be moderate and would still face credible...
Copyright 2023-2026 - www.financetom.com All Rights Reserved